Differential susceptibility of human peripheral blood T cells to suppression by environmental levels of sodium arsenite and monomethylarsonous acid

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Burchiel, Scott W ^a   Lauer, Fredine T ^a   Beswick, Ellen J ^b   Gandolfi, A Jay ^c   Parvez, Faruque ^d   Liu, Ke Jian ^a   Hudson, Laurie G ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d Department of Environmental Health Sciences Columbia University Mailman School of Public Health ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC ACID DERIVATIVE; ARSENITE SODIUM; CD28 ANTIBODY; CD3 ANTIBODY; CELL ANTIBODY; DRINKING WATER; MITOGENIC AGENT; MONOMETHYLARSONOUS ACID; PHYTOHEMAGGLUTININ; RETINOID RELATED ORPHAN RECEPTOR GAMMA; RETINOID RELATED ORPHAN RECEPTOR GAMMAT; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG; ARSENOUS ACID DERIVATIVE; ORGANOMETALLIC COMPOUND; POLLUTANT; SODIUM DERIVATIVE;

ADULT; ARTICLE; BLOOD DONOR; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOTOXICITY; IN VITRO STUDY; INHIBITION KINETICS; LYMPHOCYTE PROLIFERATION; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYCLONAL ACTIVATION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; ADOLESCENT; DRUG EFFECTS; MIDDLE AGED; POLLUTANT; TOXICITY; YOUNG ADULT;

ADOLESCENT; ADULT; ARSENITES; ENVIRONMENTAL POLLUTANTS; HUMANS; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; SODIUM COMPOUNDS; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84907494017     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109192     Document Type: Article

References (22)

1. Argos M, Kalra T, Rathouz PJ, Chen Y, Pierce B, et al. (2010). Arsenic exposure from drinking water, and all-cause and chronic-disease mortalities in Bangladesh (HEALS): a prospective cohort study. Lancet 376: 252-258.
2. Li Q, Lauer FT, Liu KJ, Hudson LG, Burchiel SW (2010). Low-dose synergistic immunosuppression of T-dependent antibody responses by polycyclic aromatic hydrocarbons and arsenic in C57BL/6J murine spleen cells. Toxicol Appl Pharmacol. 2010 Jun 15; 245(3): 344-351.
3. Ezeh PC, Lauer FT, MacKenzie D, McClain S, Liu KJ, et al. (2014). Arsenite selectively inhibits mouse bone marrow lymphoid progenitor cell development in vivo and in vitro and suppresses humoral immunity in vivo. PLoS One. Apr 8; 9(4): e93920. doi: 10.1371/journal.pone.0093920.
4. Soto-Peña GA, Luna AL, Acosta-Saavedra L, Conde P, López-Carrillo L, et al. (2006). Assessment of lymphocyte subpopulations and cytokine secretion in children exposed to arsenic. FASEB J. 20: 779-781.
5. Biswas R, Ghosh P, Banerjee N, Das JK, Sau T, et al. (2008). Analysis of T-cell proliferation and cytokine secretion in the individuals exposed to arsenic. Hum Exp Toxicol. 27: 381-386.
6. Gonsebatt ME, Vega L, Herrera LA, Montero R, Rojas E, et al. (1992). Inorganic arsenic effects on human lymphocyte stimulation and proliferation. Toxicol Appl Pharmacol. 245: 244-251.
7. Morzadec C, Bouezzedine F, Macoch M, Fardel O, Vernhet L (2012). Inorganic arsenic impairs proliferation and cytokine expression in human primary lymphocytes. Toxicology 300: 46-56.
8. Morzadec C, Macoch M, Robineau M, Sparfel L, Fardel O, et al. (2012). Inorganic arsenic represses interleukin-17A expression in human activated Th17 lymphocytes. Toxicol Appl Pharmacol 262: 217-222.
9. Drobna Z, Naranmandura H, Kubachka KM, Edwards BC, Herbin-Davis K, et al. (2009). Disruption of the arsenic (+3 oxidation state) methyltransferase gene in the mouse alters the phenotype for methylation of arsenic and affects distribution and retention of orally administered arsenate. Chem Res Toxicol. 22: 1713-1720.
10. Pierce BL, Kibriya MG, Tong L, Jasmine F, Argos M, et al. (2012) Genome-wide association study identifies chromosome 10q24.32 variants associated with arsenic metabolism and toxicity phenotypes in Bangladesh. PLoS Genet. 8: e1002522.
11. Davila DR, Romero DL, Burchiel SW (1996). Human T cells are highly sensitive to suppression of mitogenesis by polycyclic aromatic hydrocarbons and this effect is differentially reversed by alpha-naphthoflavone. Toxicol Appl Pharmacol. 139: 333-341.
12. Milstein LS, Essader A, Pellizzari ED, Fernando RA, Raymer JH, et al. (2003). Development and application of a robust speciation method for determination of six arsenic compounds present in human urine. Environ Health Perspect. 111: 293-296.
13. Gery I, Gershon RK, Waksman BH (1972). Potentiation of the T-lymphocyte response to mitogens. I. The responding cell. J Exp Med. 136: 128-142.
14. Luna AL, Acosta-Saavedra LC, Lopez-Carrillo L, Conde P, Vera E, et al. (2010). Arsenic alters monocyte superoxide anion and nitric oxide production in environmentally exposed children. Mutation Research, 283: 91-95.
15. Baroja ML, Lorre K, Van Vaeck F, Ceuppens JL (1989). The anti-T cell monoclonal antibody 9.3 (anti-CD28) provides a helper signal and bypasses the need for accessory cells in T cell activation with immobilized anti-CD3 and mitogens. Cell Immunol. 120: 205-217.
16. Kozul CD, Ely KH, Enelow RI, Hamilton JW (2009). Low-dose arsenic compromises the immune system response to influenza A infection in vivo. Environ Health Perspect 117: 1441-1447.
17. Eblin KE, Bredfeldt TG, Buffington S, Gandolfi AJ (2007). Mitogenic signal transduction caused by monomethylarsonous acid in human bladder cells: role in arsenic-induced carcinogenesis. Toxicol Sci. 95: 321-330.
18. Chowdhury R, Chatterjee R, Giri AK, Mandal C, Chaudhuri K (2010). Arsenic-induced cell proliferation is associated with enhanced ROS generation, Erk signaling and Cyclin A expression. Toxicol Lett. 198: 263-71.
19. Soto-Peña GA, Vega L (2008). Arsenic interferes with the signaling transduction pathway of T cell receptor activation by increasing basal and induced phosphorylation of Lck and Fyn in spleen cells. Toxicol Appl Pharmacol. 230: 216-226.
20. Hall M, Chen Y, Ahsan H, Slavkovich V, A van Geen, et al. (2006). Blood arsenic as a biomarker of arsenic exposure: results from a prospective study. Toxicology. 225: 225-233.
21. Engström K, Vahter M, Mlakar SJ, Concha G, Nermell B, et al. (2011) Polymorphisms in arsenic (+III oxidation state) methyltransferase (AS3MT) predict gene expression of AS3MT as well as arsenic metabolism. Environ Health Perspect. 119: 182-188.
22. Pierce BL, Tong L, Argos M, Gao J, Farzana J, et al. (2013). Arsenic metabolism efficiency has a causal role in arsenic toxicity: Mendelian randomization and gene-environment interaction. Int J Epidemiol. 42: 1862-1871. doi: 10.1093/ije/dyt182.